Official Title
Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers
Brief Summary

The purpose of this study is to identify healthcare workers with SARS CoV 2 antibodies who have not been previously diagnosed and are presumed COVID-19 negative, then determine the level of immunity in this population which could inform further decisions about widespread antibody testing in a healthcare worker population.

Detailed Description

Enrolled participants will complete a survey gauging their level of confidence they will be
antibody positive. Participants will then complete serologic testing for SARS CoV 2 IgG
antibodies. The study will characterize the prevalence of antibody positivity in this
population and assess whether there is a correlation between a pre-test confidence level
using a Likert scale and actual antibody positivity.

Completed
SARS-CoV 2
COVID-19

Other: Serologic testing

COVID19 IgG antibody testing to be performed

Eligibility Criteria

Inclusion Criteria:

- Age ≥ 18 years old.

- Mayo Clinic employee in procedural and surgical area.

- Suspected COVID-19 exposure.

- Completed PCR test twice with negative results.

Exclusion Criteria:

- Refusal to participate in this study.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Mayo Clinic in Florida
Jacksonville, Florida, United States

Mark Parkulo, MD, Principal Investigator
Mayo Clinic

NCT Number